DNA polymerases of Walker 256 carcinosarcoma.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D000998:Antiviral Agents / Q000494:pharmacology; D002279:Carcinoma 256, Walker / Q000201:enzymology*; D002478:Cells, Cultured; D002498:Centrifugation; D002845:Chromatography; D002848:Chromatography, DEAE-Cellulose; D004254:DNA Nucleotidyltransferases / Q000032:analysis / Q000037:antagonists & inhibitors / Q000302:isolation & purification / Q000378:metabolism*; D012194:RNA-Directed DNA Polymerase / Q000032:analysis / Q000302:isolation & purification; D051381:Rats; D018894:Reverse Transcriptase Inhibitors
D000970:Antineoplastic Agents; D000998:Antiviral Agents; D018894:Reverse Transcriptase Inhibitors; D004254:DNA Nucleotidyltransferases; D012194:RNA-Directed DNA Polymerase